Please use this identifier to cite or link to this item:
|Title:||Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis|
|Authors:||Cury, Didia Bismara [UNIFESP]|
Mizsputen, Sender Jankiel [UNIFESP]
Versolato, Clara [UNIFESP]
Miiji, Luciana Odashiro [UNIFESP]
Pereira, Edson [UNIFESP]
Delboni, Maria Aparecida [UNIFESP]
Schor, Nestor [UNIFESP]
Moss, Alan C.
Universidade Federal de São Paulo (UNIFESP)
|Citation:||Cellular Immunology. San Diego: Academic Press Inc Elsevier Science, v. 282, n. 1, p. 66-70, 2013.|
|Abstract:||Background and aim: Serum calprotectin is elevated in patients with inflammatory bowel disease (IBD). Whether it correlates other markers of disease activity is unknown. the aim of this study was to correlate serum calprotectin with biochemical and histological measures of intestinal inflammation.Materials and methods: TNBS colitis was induced in wistar rats, and serial blood samples were collected at 0, 3, and 12 days. Animals were subsequently sacrificed for pathological evaluation at day 12. Serum calprotectin and cytokines were measured by ELISA. Pathologic changes were classified at the macroscopic and microscopic levels.Results: TNBS colitis induced elevated serum calprotectin, TNF and IL-6 within 24 h. Levels of serum calprotectin remained elevated in parallel to persistence of loose stool and weight loss to day 12. Serum calprotectin levels correlated with serum levels of TNF-alpha, and IL6 (p < 0.001), but not CRP. Animals with liquid stool had significantly higher levels of serum calprotectin than control animals. There was a correlation between macroscopic colitis scores, and levels of serum calprotectin.Conclusion: Serum calprotectin levels correlate with biochemical and histological markers of inflammation in TNBS colitis. This biomarker may have potential for diagnostic use in patients with IBD. (C) 2013 Elsevier Inc. All rights reserved.|
|Appears in Collections:||Artigo|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.